Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Diaceutics PLC - UK testing laboratories company - Wins data subscription contract with an unnamed "top five global life sciences company" worth over USD2.5 million, with proceeds to be realised over its three-year term. Says it is its largest data subscription contract to date.
Data will be supplied by Diaceutics' DXRX platform, which uses machine learning to analyse real-world, real-time diagnostic testing data from network of laboratories worldwide, and then provides services to improve testing.
"This significant contract adds to a strong start to the year and demonstrates the ability of the DXRX platform to improve the quality and long-term visibility of the revenues of the business," said Founder & Chief Executive Office Peter Keeling.
Current stock price: 114.75 pence, up 3.9%
12-month change: down 13%
By Elizabeth Winter; elizabethwinter@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.